PatientsLikeMe : Amantadine Treatment Evaluations

Select a community: All Communities

All Communities
Neurological Conditions
MS (Multiple Sclerosis)
Parkinson’s Disease
ALS (Amyotrophic Lateral Sclerosis) / MND (Motor Neuron Disease)
PLS (Primary Lateral Sclerosis)
PMA (Progressive Muscular Atrophy)
PSP (Progressive Supranuclear Palsy)
CBD (Corticobasal Degeneration)
MSA (Multiple System Atrophy)
Devic’s Neuromyelitis Optica
Neuroendocrine Conditions
Fibromyalgia
Mood Conditions
Anxiety
Bipolar
Depression
Obsessive-Compulsive Disorder
Post-Traumatic Stress Disorder
Immune Conditions
HIV/AIDS

Home > Amantadine Treatment Evaluations

You appear to have JavaScript disabled in your browser. PatientsLikeMe relies on JavaScript and Cookies to deliver the best possible experience to you. How do I enable JavaScript?

See full Amantadine Community Report

One of 37 patient evaluations for Amantadine

mtsonex180

Sex: M

Mouth/throat: mild

Arms: mild

Chest: none

Legs: mild

See profile
by mtsonex180
Dec 05, 2008

dosage:: 300 mg daily
time on dosage:: about 4 years
purpose:: Treat Parkinson's

0665e2746c1a4457f759e893ca886918db6c5823

EfficacySlight
Side-effectsNone
AdherenceUsually
BurdenSlight

Treat Parkinson's

Burden: COST
Cost: $25-49 monthly

0 helpful marks

PatientsLikeMe ™